"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."

Margaret Mead
Original article
peer-reviewed

Ethnic and Age Disparities in Patients Taking Long-acting Injectable Atypical Antipsychotics



Abstract

Introduction

This study will determine whether different ethnicities and different age groups receive equal amounts of long-acting atypical antipsychotics in comparison to their oral equivalents.

Methods

Secondary analyses of data from the Los Angeles County Department of Health Services Electronic Health Record (total N=63,134 inpatient visits) were performed. Chi-squared statistics were used to compare ethnicity and age with the use of either risperidone injectable or paliperidone palmitate (r-LAIs) versus risperidone oral.

Results

Among the 63,134 total inpatient visits, there were 3,011 patient visits that included the use of an atypical antipsychotic. Of these 3,011 visits, 452 (15.0%) were on r-LAIs and 2,559 (85.0%) were on risperidone oral. No statistically significant disparities were identified with the use of r-LAIs as compared to oral risperidone amongst ethnic groups (chi-square = 0.88, df = 3, p = 0.831). However, there was a statistically significant difference with the use of r-LAIs as compared to oral Risperidone amongst age groups, favoring younger patients (chi-square = 13.46, df = 3, p < 0.004).

Conclusion

Our data indicate a lack of ethnic disparities in prescribing long-acting atypical antipsychotics and an increased percentage of younger patients being treated with atypical depot antipsychotics over their oral equivalents.



Want to read more?

Create a free account to continue reading this article.

Already a member? Login.



Original article
peer-reviewed

Ethnic and Age Disparities in Patients Taking Long-acting Injectable Atypical Antipsychotics


Author Information

Mateen Soleman

Western, Western University

Nikki Lam

College of Medicine, Northeast Ohio Medical University (NEOMED)


Ethics Statement and Conflict of Interest Disclosures

Human subjects: Consent was obtained by all participants in this study. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.


Original article
peer-reviewed

Ethnic and Age Disparities in Patients Taking Long-acting Injectable Atypical Antipsychotics


Figures etc.

Share
Original article
peer-reviewed

Ethnic and Age Disparities in Patients Taking Long-acting Injectable Atypical Antipsychotics

Mateen Soleman">Mateen Soleman, Nikki Lam">Nikki Lam, Benjamin K. Woo">Benjamin K. Woo

  • Author Information
    Mateen Soleman

    Western, Western University

    Nikki Lam

    College of Medicine, Northeast Ohio Medical University (NEOMED)

    Benjamin K. Woo Corresponding Author

    UCLA


    Ethics Statement and Conflict of Interest Disclosures

    Human subjects: Consent was obtained by all participants in this study. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

    Acknowledgements


    Article Information

    Published: October 12, 2017

    DOI

    10.7759/cureus.1772

    Cite this article as:

    Soleman M, Lam N, Woo B K (October 12, 2017) Ethnic and Age Disparities in Patients Taking Long-acting Injectable Atypical Antipsychotics. Cureus 9(10): e1772. doi:10.7759/cureus.1772

    Publication history

    Received by Cureus: September 25, 2017
    Peer review began: October 06, 2017
    Peer review concluded: October 10, 2017
    Published: October 12, 2017

    Copyright

    © Copyright 2017
    Soleman et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 3.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

    License

    This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Introduction

This study will determine whether different ethnicities and different age groups receive equal amounts of long-acting atypical antipsychotics in comparison to their oral equivalents.

Methods

Secondary analyses of data from the Los Angeles County Department of Health Services Electronic Health Record (total N=63,134 inpatient visits) were performed. Chi-squared statistics were used to compare ethnicity and age with the use of either risperidone injectable or paliperidone palmitate (r-LAIs) versus risperidone oral.

Results

Among the 63,134 total inpatient visits, there were 3,011 patient visits that included the use of an atypical antipsychotic. Of these 3,011 visits, 452 (15.0%) were on r-LAIs and 2,559 (85.0%) were on risperidone oral. No statistically significant disparities were identified with the use of r-LAIs as compared to oral risperidone amongst ethnic groups (chi-square = 0.88, df = 3, p = 0.831). However, there was a statistically significant difference with the use of r-LAIs as compared to oral Risperidone amongst age groups, favoring younger patients (chi-square = 13.46, df = 3, p < 0.004).

Conclusion

Our data indicate a lack of ethnic disparities in prescribing long-acting atypical antipsychotics and an increased percentage of younger patients being treated with atypical depot antipsychotics over their oral equivalents.



Want to read more?

Create a free account to continue reading this article.

Already a member? Login.



Mateen Soleman

Western, Western University

Nikki Lam

College of Medicine, Northeast Ohio Medical University (NEOMED)

Benjamin K. Woo, M.D.

UCLA

For correspondence:
bewoo@dhs.lacounty.gov

Mateen Soleman

Western, Western University

Nikki Lam

College of Medicine, Northeast Ohio Medical University (NEOMED)

Benjamin K. Woo, M.D.

UCLA

For correspondence:
bewoo@dhs.lacounty.gov